Cargando…
RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer
BACKGROUND: While prostate cancer can often manifest as an indolent disease, the development of locally-advanced or metastatic disease can cause significant morbidity or mortality. Elucidation of molecular mechanisms contributing to disease progression is crucial for more accurate prognostication an...
Autores principales: | Mesci, Aruz, Lucien, Fabrice, Huang, Xiaoyong, Wang, Eric H., Shin, David, Meringer, Michelle, Hoey, Christianne, Ray, Jessica, Boutros, Paul C., Leong, Hon S., Liu, Stanley K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466739/ https://www.ncbi.nlm.nih.gov/pubmed/30987640 http://dx.doi.org/10.1186/s12967-019-1878-3 |
Ejemplares similares
-
Spurious elevation of Prostate‐specific antigen associated with shingles in a prostate cancer patient undergoing active surveillance
por: Mesci, Aruz, et al.
Publicado: (2018) -
Urinary biomarkers in prostate cancer: to the miRnome and beyond
por: Hoey, Christianne, et al.
Publicado: (2020) -
MicroRNA-198 suppresses prostate tumorigenesis by targeting MIB1
por: Ray, Jessica, et al.
Publicado: (2019) -
Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis
por: Mesci, Aruz, et al.
Publicado: (2017) -
Collagen and Calcium Binding EGF Domains 1 (CCBE1) in cancer – a new role past lymphatics?
por: Mesci, Aruz, et al.
Publicado: (2017)